Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Methods in Enzymology
|
March 4, 2017
Dynamics of Atg5-Atg12-Atg16L1 Aggregation and Deaggregation
P Kharaziha, T Panaretakis
International Review of Cell and Molecular Biology
|
August 31, 2016
Metabolic and Signaling Functions of Cancer Cell-Derived Extracellular Vesicles
P Fonseca, I Vardaki, A Occhionero, et al.
Carcinogenesis
|
December 11, 1999
Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells
I G Shabalina, T Panaretakis, A Bergstrand, et al.
Toxicology and Applied Pharmacology
|
May 15, 2001
Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid
T Panaretakis, I G Shabalina, D Grandér, et al.
Cell Death and Differentiation
|
November 17, 2007
Molecular characteristics of immunogenic cancer cell death
A Tesniere, T Panaretakis, O Kepp, et al.
The Journal of Membrane Biology
|
September 8, 2001
Proton- and sodium-coupled phosphate transport systems and energy status of Yarrowia lipolytica cells grown in acidic and alkaline conditions
R Zvyagilskaya, O Parchomenko, N Abramova, et al.
Cell Death & Disease
|
March 4, 2011
Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia
M Wemeau, O Kepp, A Tesnière, et al.
Cell Death and Differentiation
|
February 17, 2009
Horizontal transfer of tumor DNA to endothelial cells in vivo
J Ehnfors, M Kost-Alimova, N Luna Persson, et al.
Cell Death and Differentiation
|
November 24, 2007
Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin
R Tufi, T Panaretakis, K Bianchi, et al.
Cell Death & Disease
|
January 27, 2012
Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells
P Kharaziha, P Rodriguez, Q Li, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Methods in Enzymology
|
March 4, 2017
Dynamics of Atg5-Atg12-Atg16L1 Aggregation and Deaggregation
P Kharaziha, T Panaretakis
International Review of Cell and Molecular Biology
|
August 31, 2016
Metabolic and Signaling Functions of Cancer Cell-Derived Extracellular Vesicles
P Fonseca, I Vardaki, A Occhionero, et al.
Carcinogenesis
|
December 11, 1999
Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells
I G Shabalina, T Panaretakis, A Bergstrand, et al.
Toxicology and Applied Pharmacology
|
May 15, 2001
Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid
T Panaretakis, I G Shabalina, D Grandér, et al.
Cell Death and Differentiation
|
November 17, 2007
Molecular characteristics of immunogenic cancer cell death
A Tesniere, T Panaretakis, O Kepp, et al.
The Journal of Membrane Biology
|
September 8, 2001
Proton- and sodium-coupled phosphate transport systems and energy status of Yarrowia lipolytica cells grown in acidic and alkaline conditions
R Zvyagilskaya, O Parchomenko, N Abramova, et al.
Cell Death & Disease
|
March 4, 2011
Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia
M Wemeau, O Kepp, A Tesnière, et al.
Cell Death and Differentiation
|
February 17, 2009
Horizontal transfer of tumor DNA to endothelial cells in vivo
J Ehnfors, M Kost-Alimova, N Luna Persson, et al.
Cell Death and Differentiation
|
November 24, 2007
Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin
R Tufi, T Panaretakis, K Bianchi, et al.
Cell Death & Disease
|
January 27, 2012
Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells
P Kharaziha, P Rodriguez, Q Li, et al.
Page
of 2